Risk–benefit analysis of vaccination in elite athletes differs significantly from that of the general population, providing the rationale for specific vaccination guidelines

Risk of infection is higher in athletes due to worldwide traveling and close contact with teammates or opponents. Moreover, consequences of infection are more serious, since even mild infections might be relevant for individual performance

Adverse reactions could be reduced by selecting the optimal vaccine, the optimal time point for vaccination and the correct vaccination technique